2. Cell Cycle/DNA Damage
  3. CDK
  4. Cyclin A/B RxL-IN-1

Cyclin A/B RxL-IN-1 is a inhibitor targeting the Cyclin A/B RxL interaction at the hydrophobic patch (HP). Cyclin A/B RxL-IN-1 inhibits Cyclin A with an IC50 of 0.12 μM. Cyclin A/B RxL-IN-1 demonstrates antitumor efficacy in mouse cell line-derived xenograft (CDX) models. CDK-IN-19 can be used for the study of E2F-driven cancers such as small-cell lung cancer (SCLC).

For research use only. We do not sell to patients.

Cyclin A/B RxL-IN-1

Cyclin A/B RxL-IN-1 Chemical Structure

CAS No. : 3036231-62-3

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Cyclin A/B RxL-IN-1 Related Antibodies

Top Publications Citing Use of Products

View All CDK Isoform Specific Products:

View All Isoforms
CDK1 CDK2 CDK3 CDK4 CDK5 CDK6 CDK7 CDK8 CDK9 CDK11 CDK12 CDK13 CDK14 CDK16 CDK19 CDC CLK Pho85 CDK10 CDK15 CDK17 CDK18 CDK20 PITSLRE

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Cyclin A/B RxL-IN-1 is a inhibitor targeting the Cyclin A/B RxL interaction at the hydrophobic patch (HP). Cyclin A/B RxL-IN-1 inhibits Cyclin A with an IC50 of 0.12 μM. Cyclin A/B RxL-IN-1 demonstrates antitumor efficacy in mouse cell line-derived xenograft (CDX) models. CDK-IN-19 can be used for the study of E2F-driven cancers such as small-cell lung cancer (SCLC)[1].

In Vitro

Cyclin A/B RxL-IN-1 (Compound 34) (5 days) inhibits proliferation of RB1/E2F-dysregulated small-cell lung cancer (SCLC) cells, with GI50 of 0.016 μM in NCI-H69 cells and 0.048 μM in NCI-H1048 cells[1].
Cyclin A/B RxL-IN-1 exhibits selective binding affinity to Cyclin A/B, with Cyclin A FP2 IC50 of 0.079 μM, and Cyclin E FP2 IC50 of 0.958 μM[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cyclin A/B RxL-IN-1 Related Antibodies
In Vivo

Cyclin A/B RxL-IN-1 (Compound 34) (50-100 mg/kg, i.p., once daily, 14 days) induces tumor growth inhibition in NCI-H1048 SCLC xenograft model[1].
Cyclin A/B RxL-IN-1 (100 mg/kg, i.p., once daily, 18 days) demonstrates potent antitumor activity in NCI-H69 SCLC xenograft model[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: NCI-H1048 cells (3 × 106 in 100 μL mixture of HITES media and Matrigel at 1:1 ratio) were subcutaneously implanted into the flanks of 6-8-week-old female BALB/c nude mice[1]
Dosage: 50, 100 mg/kg
Administration: i.p., once daily, 14 days
Result: Achieved tumor growth inhibition.
Showed no significant changes in body weight.
Animal Model: NCI-H69 cells (5 × 106 in 100 μL mixture of serum-free RPMI-1640 media and ECM gel at 1:1 ratio) were subcutaneously implanted into the flanks of 7-8-week-old female Nude mice[1]
Dosage: 100 mg/kg
Administration: i.p., once daily, 18 days
Result: Achieved tumor growth inhibition.
Molecular Weight

972.93

Formula

C46H63Cl2F4N7O7
CAS No.
SMILES

CC(C[C@@H]1NC([C@H](CCCCNC(C(C)(NC([C@@H](N(C1=O)C)CC2=CC(Cl)=CC=C2Cl)=O)C)=O)N(C([C@H](C3CC3)NC([C@@H]4C[C@H](CN4C(C5(CC6(C5)CCC6)C(F)(F)F)=O)F)=O)=O)C)=O)C
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Cyclin A/B RxL-IN-1 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Cyclin A/B RxL-IN-13036231-62-3CDKCyclin dependent kinasesmall-cell lung cancerCyclin A/BRB1/E2F-dysregulated cancer cellsInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Cyclin A/B RxL-IN-1
Cat. No.:
HY-175729
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.